Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04926090 · ClinicalTrials.gov registry record · NA
Developing Mental Health Supports for Autistic Students
A NA study of Autism Spectrum Disorder and Depression, Anxiety, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT04926090: Completed NA study of Autism Spectrum Disorder and Depression, Anxiety, sponsored by Rutgers, The State University of New Jersey.
NCT04926090 is a NA study of Autism Spectrum Disorder and Depression, Anxiety that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 19 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04926090, a NA study of Autism Spectrum Disorder and Depression, Anxiety, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study aims to expand the availability of emotional supports in order to promote successful transitions and longer-term outcomes for autistic students in PSE.
Primary Outcome
The PHQ-9, assessed weekly for first 6 weeks and biweekly for remaining 9 weeks, is a 9-item questionnaire of psychological function over the past week with all items on a "0" (not at all) to "3" (nearly every day) scale. Higher scores equal more distress.
Conditions Studied
Interventions
- BEHAVIORAL Emotional Support Plan - Clinician Guided (ESP-C)
- BEHAVIORAL Emotional Support Plan - Self Guided (ESP-S)
Study Locations (1)
New Jersey
- Rutgers University - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-07-26 |
| Est. Completion | 2022-07-27 |
| Phase | NA |
What the finished NCT04926090 record still lists
NCT04926090 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Emotional Support Plan - Clinician Guided (ESP-C) is the first listed.
NCT04926090 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04926090 about?
NCT04926090 is a clinical study titled "Developing Mental Health Supports for Autistic Students". The present study aims to expand the availability of emotional supports in order to promote successful transitions and longer-term outcomes for autistic students in PSE.
What is the current status of trial NCT04926090?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-07-26. Estimated completion is 2022-07-27.
What conditions does trial NCT04926090 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Depression, Anxiety.
What interventions are being tested in trial NCT04926090?
The interventions under investigation include: Emotional Support Plan - Clinician Guided (ESP-C) (BEHAVIORAL), Emotional Support Plan - Self Guided (ESP-S) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04926090?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04926090 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04926090's enrollment target sits among peer trials
19 203rd of 224 higher than 20 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI